Sichuan Kelun Pharmaceutical Co Ltd Class A 002422
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 33.71
- Day Range
- CNY 33.23–34.04
- 52-Week Range
- CNY 21.60–35.49
- Bid/Ask
- CNY 33.67 / CNY 33.68
- Market Cap
- CNY 53.93 Bil
- Volume/Avg
- 12.6 Mil / 16.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- 18.42
- Price/Sales
- 2.35
- Dividend Yield (Trailing)
- 1.83%
- Dividend Yield (Forward)
- 1.83%
- Total Yield
- 1.83%
Company Profile
Sichuan Kelun Pharmaceutical Co Ltd is a China-based Pharmaceutical company mainly focused on the production and sales of injection products, including products for glucose injection and sodium chloride injection. It manufactures and sells high-volume injections (infusions), small-volume injections (water needles), sterile powder injections (containing powdered and freeze-dried powder). Its products include tablets, capsules, capsules, granules, oral liquids, peritoneal dialysis fluids, raw material medicines, medical packaging materials, medical instruments, and antibiotic intermediates.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Large Core
- Total Number of Employees
- 18,422
- Website
- http://www.kelun.com
Comparables
Valuation
Metric
|
002422
|
002907
|
002900
|
---|---|---|---|
Price/Earnings (Normalized) | 18.42 | 203.41 | 109.88 |
Price/Book Value | 2.42 | 3.63 | 1.47 |
Price/Sales | 2.35 | 8.22 | 2.85 |
Price/Cash Flow | 10.18 | 46.75 | — |
Price/Earnings
002422
002907
002900
Financial Strength
Metric
|
002422
|
002907
|
002900
|
---|---|---|---|
Quick Ratio | 1.43 | 4.02 | 1.08 |
Current Ratio | 1.98 | 5.05 | 1.36 |
Interest Coverage | 15.05 | — | 2.29 |
Quick Ratio
002422
002907
002900
Profitability
Metric
|
002422
|
002907
|
002900
|
---|---|---|---|
Return on Assets (Normalized) | 7.09% | 1.56% | 1.15% |
Return on Equity (Normalized) | 13.68% | 1.80% | 1.88% |
Return on Invested Capital (Normalized) | 9.30% | 1.41% | 1.33% |
Return on Assets
002422
002907
002900
Drug Manufacturers - General Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Nmvfkcwdxm | Xmpz | $732.9 Bil | |
JNJ
| Johnson & Johnson | Bbmbslhk | Drkj | $367.4 Bil | |
MRK
| Merck & Co Inc | Yvpvvfc | Zlw | $331.5 Bil | |
ABBV
| AbbVie Inc | Jlyzdps | Slg | $290.2 Bil | |
AZN
| AstraZeneca PLC ADR | Gdstcdvg | Mdrj | $239.3 Bil | |
RHHBY
| Roche Holding AG ADR | Fgsvlsck | Ttqfm | $211.1 Bil | |
NVS
| Novartis AG ADR | Fgrwxjqpj | Tgc | $210.2 Bil | |
AMGN
| Amgen Inc | Qdyhqxdyn | Cpd | $167.6 Bil | |
PFE
| Pfizer Inc | Cnrjtbhln | Kty | $162.3 Bil | |
SNY
| Sanofi SA ADR | Bsndqfdbd | Jzh | $122.8 Bil |